Revvity | PKI - Operating Profit


Revvity reported $124.63M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Agilent USD 444M 45M Jun/2026
Align Technology USD 193.04M 1.72M Sep/2026
Bio Techne USD 55.82M 39.18M Sep/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Bruker USD 83.5M 13.9M Sep/2026
Celltrion KRW 19.31B 6.4B Jun/2026
Charles River Laboratories USD 202.64M 82.75M Sep/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Danaher USD 1.25B 118M Sep/2026
Dentsply International USD 38M 46M Sep/2026
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Dianthus Therapeutics USD -61.48M 14.95M Jun/2026
Divis Laboratories Ltd INR 14.24B 2.95B Sep/2026
Edwards Lifesciences USD 542.7M 23.2M Sep/2026
Illumina USD 305M 45M Sep/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Kangmei Pharma CNY -35.26M 24.32M Jun/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Laboratory Of America USD 418M 38.7M Sep/2026
Malin Corporation EUR -1.1M 400K Dec/2024
Medical Developments International AUD -36K 444K Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Organigram Holdings CAD 5.33M 15.12M Jun/2026
Ovoca Bio EUR -173K 990K Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Pharma Mar EUR 7.65M 9.06M Sep/2026
Qiagen NV USD 141.4M 24.77M Jun/2026
Quest Diagnostics USD 479M 20M Sep/2026
Quidel USD 12.1M 27.4M Sep/2026
Repligen USD 24.31M 3.18M Sep/2026
Revvity USD 124.63M 1.51M Sep/2026
Sartorius EUR 179.8M 15.8M Sep/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Tilray USD -20.01M 9.34M Sep/2025
Waters USD -86M 234M Jun/2026
Zealand Pharma A/S -539M 168.05M Mar/2026
Zz Pientze Pharmaceu CNY 222.81M 140.02M Sep/2026